NCI awarded ATCC a five-year indefinite-delivery/indefinite-quantity contract to support the Division of Cancer Epidemiology and Genetics’ Molecular Epidemiology Assay Support program.
DCEG’s mission is to conduct population and multidisciplinary research to discover the genetic and environmental determinants of cancer and new approaches to cancer prevention. The MEAS program provides support services for studies on the genetic and other cellular events that influence the onset of different types of cancer.
Under the contract, ATCC will provide collection supplies to study sites; perform aliquoting and advanced molecular assays; and provide short-term storage for human biospecimens and environmental samples obtained through family and population-based collection efforts, both domestically and internationally. ATCC will track all specimens using a customized biospecimen inventory and resource management system, ensuring that specimens are safeguarded appropriately for use in long-term epidemiology research projects.
“We understand that the proper collection, tracking and storage of specimens is of critical importance to cancer research, and take pride in maintaining and distributing these unique samples to the global research community,” said Joseph Leonelli, vice president for ATCC’s Microbiology and Government Solutions business.
